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2Interleukin-18 (IL18) participates in atherogenesis through several putative 
mechanisms
1,2
. Interruption of IL18 action reduces atherosclerosis in mice
3,4
. This 
study shows that the absence of IL18 receptor (IL18r) does not affect atherosclerosis 
in apolipoprotein E-deficient (Apoe
–/–
) mice, nor does it affect IL18 cell surface 
binding or signaling. IL18 antibody-mediated immunoprecipitation identified an 
interaction between IL18 and Na-Cl co-transporter (NCC), a 12-transmembrane-
domain ion transporter protein preferentially expressed in the kidney
5
. Yet, we find 
NCC expression and colocalization with IL18r in atherosclerotic lesions and both 
molecules form a complex. IL18 also binds to the cell surface and induces cell
signaling and down-stream cytokine expression in NCC-transfected COS-7 cells that 
do not express IL18r. In Apoe
–/–
mice, combined deficiency of IL18r and NCC, but 
not single deficiency, protects mice from atherosclerosis. Peritoneal macrophages 
from Apoe
–/–
mice or those lacking IL18r or NCC respond to IL18 binding or IL18 
induction of cell signaling and cytokine and chemokine production, but those with 
combined deficiency of IL18r and NCC do not. This study identifies NCC as an 
IL18-binding protein that coordinates with IL18r in cell signaling, inflammatory 
molecule expression, and experimental atherogenesis.
IL18 polarizes Th1 cells
1,2
and induces production of inflammatory cytokines, 
chemokines, and vascular adhesion molecules
2,6-8
. Prior studies with mice deficient in 
IL18 (Il18
–/–
), its receptor IL18r (Il18r
–/–
), or soluble receptors demonstrate the 
contribution of IL18 to several inflammatory diseases
9-11
. Atherosclerotic lesions but not 
normal human aortas express high levels of IL18 and IL18r in macrophages, T cells,
3endothelial cells (ECs), and smooth-muscle cells (SMCs)
12,13
. In atherosclerosis-prone 
apolipoprotein E–deficient (Apoe
–/–
) mice, the absence of IL18 or blockade of IL18 
signaling reduces atherosclerosis and lesion inflammation
3,4
. Intraperitoneal 
administration of IL18 in Apoe
–/–
mice enhances lesion burden and inflammation
14,15
.
IL18r is a heterodimer with a low IL18-binding affinity
16
. Absence of IL18r leads to 
reduced NK cell IFN- production and impaired Th1 cell signaling and differentiation
17
.
Yet, Apoe
–/–
and Apoe
–/–
Il18r
–/–
littermates showed no differences in atherogenesis. In 
Apoe
–/–
mice, the presence or absence of IL18r did not affect aortic root intimal area, or 
lesion macrophage, CD4
+
T-cell, or SMC contents (Fig. 1a) — suggesting IL18 action on 
target cells that is independent of, or in addition to, the known IL18r. Mouse ECs from 
Apoe
–/–
and Apoe
–/–
Il18r
–/–
mice incubated with biotinylated IL18, showed no differences 
in cell surface IL18 binding, competable by a 5~10-fold excess of unlabeled IL18 (Fig. 
1b). ECs from Apoe
–/–
and Apoe
–/–
Il18r
–/–
mice showed a similar pattern of protein 
tyrosine phosphorylation after 30 minutes of incubation with IL18, as detected by 
immunoblot with anti-phospho (p)-tyrosine antibody. Heat-inactivated IL18 did not elicit 
these activities (Fig. 1c). These data pointed to the presence of alternative molecules that 
mediate cell-surface IL18 binding and downstream signaling. Incubation of ECs from 
Apoe
–/–
Il18r
–/–
mice with IL18 for 15 minutes followed by immunoprecipitation with an 
anti-mouse IL18 polyclonal antibody identified possible cell-surface IL18-binding 
molecules. Silver-stained SDS-PAGE showed two major bands between 85 to 150 kDa in 
series eluates from IL18-treated ECs (Fig. 1d). Mass spectrometry identified a 125-kDa 
Na-Cl co-transporter (NCC) in addition to multiple matrix protein fragments (data not 
shown). 
4NCC is a plasma membrane ion co-transporter expressed as a homodimer in 
kidney distal convoluted tubules, where it participates in electrolyte homeostasis
18
,
although other tissues express low levels of NCC
5,19
. We detected abundant NCC mRNA 
in mouse kidney, but also low levels in the heart, lung, and liver by RT-PCR 
(Supplementary Fig. 1). Immunostaining using an anti-human/mouse NCC polyclonal 
antibody revealed no NCC expression in normal human or mouse aortas (Fig. 2a), but 
abundant NCC expression in human fatty streaks (Supplementary Fig. 2) and advanced 
atherosclerotic lesions (Fig. 2b), localized to areas positive for IL18r and CD68
+
macrophages. Tests of antibody specificity confirmed NCC expression in kidney distal 
tubules from Apoe
–/–
mice, but not in those from Apoe
–/–
Ncc
–/–
mice (Supplementary 
Fig. 3). Macrophages, SMCs, and ECs in atherosclerotic lesions from Apoe
–/–
mice 
expressed NCC (Fig. 2c). Immunofluorescent staining confirmed colocalization of NCC 
and IL18r in macrophages, SMCs, and ECs in lesions from Apoe
–/–
mice (Fig. 2d). RT-
PCR demonstrated that IL18 induced NCC expression in mouse peritoneal macrophages 
by 65-fold, but had negligible effect on T cells. Immunostaining revealed induction of 
NCC by IL18 in macrophages and T cells from Apoe
–/–
mice (Fig. 2e). Immunoblot 
showed that IL18, IL1 or TNF- increased NCC expression in mouse ECs and SMCs, 
with the same molecular weight as those expressed in NCC/pcDNA3.1-transfected COS-
7 cells (Fig. 2f). Immunoprecipitation with mouse anti-mouse IL18r antibody followed 
by immunoblot with the rabbit anti-mouse NCC antibody in macrophage lysates 
demonstrated an enhanced complex formation between IL18r and NCC in IL18-treated 
macrophages from Apoe
–/–
mice but not those from Apoe
–/–
Ncc
–/–
mice (Fig. 2g). To 
study NCC and its interaction with IL18, we subcloned NCC full-length cDNA into a 
5pcDNA3.1 vector. Immunoblot revealed mouse NCC in NCC-transfected COS-7 cells as 
a doublet band around 125-kDa, due to differential protein glycosylations 
(Supplementary Fig. 4)
18
. FACS analysis demonstrated surface binding of biotin-
conjugated IL18, but not heat-inactivated biotin-IL18 on NCC-transfected COS-7 cells 
30 minutes after induction (Fig. 2h). FITC-conjugated IL18 binding to NCC-transfected 
COS-7 cells, which do not express IL18r in the presence or absence of IL18 (data not 
shown), showed a higher binding affinity (dissociation constant Kd = 17.3 nM) than 
previously reported IL18 binding on IL18r-transfected COS-1 cells (Kd = 46 nM)
16
(Fig. 
2h). Treatment with IL18, but not heat-inactivated IL18 for 30 minutes also increased 
protein tyrosine phosphorylation in NCC-transfected COS-7 cells, compared with those
transfected with empty vector (Fig. 2h), indicating that IL18 interacts with NCC and 
yields biological consequences. 
Insignificant differences in atherogenesis between Apoe
–/–
and Apoe
–/–
Il18r
–/–
mice (Fig. 1a) and binding of IL18 on NCC-transfected COS-7 cells and consequent cell 
signaling (Fig. 2h) suggest that NCC mediates IL18 functions in atherogenesis in the 
presence and absence of IL18r. To test this hypothesis, we crossbred NCC-deficient mice 
(Ncc
–/–
, on a C57BL/6/129S background)
20
with Apoe
–/–
and Il18r
–/–
mice and generated 
Apoe
–/–
Ncc
–/–
, Apoe
–/–
Il18r
–/–
, and Apoe
–/–
Ncc
–/–
Il18r
–/–
littermate mice with their 
background identity confirmed with a genome scanning analysis (data not shown). 
Compared with Apoe
–/–
and Apoe
–/–
Il18r
–/–
mice (Fig. 1a), Apoe
–/–
Ncc
–/–
mice showed no 
significant differences in aortic root atherosclerotic lesion intima area and thoracic-
abdominal aorta lipid deposition, although this study did not characterize lesions from the 
aortic arches. In contrast, aortic root intimal size (P < 0.001) and thoracic-abdominal 
6aorta lipid deposition (P < 0.002) decreased significantly in Apoe
–/–
Ncc
–/–
Il18r
–/–
mice 
(Fig. 3a/3b), suggesting that IL18r and NCC coordinately mediate IL18 function. IL18r 
may compensate the NCC loss of function, and vice versa. Lesion Mac-3
+
macrophage 
content (P < 0.001), major histocompatibility class-II (MHC-II)–positive areas (P < 
0.002), and -actin–positive SMC areas (P < 0.01) also decreased significantly in Apoe
–/–
Ncc
–/–
Il18r
–/–
mice but not in Apoe
–/–
Il18r
–/–
or Apoe
–/–
Ncc
–/–
mice, compared with Apoe
–/–
mice (Fig. 3c/3d). Lesion CD4
+
T cell numbers did not differ between the groups (Fig. 
3c). Aortic root lesion lipid deposition (Fig. 3e) decreased in Apoe
–/–
Il18r
–/–
mice (P =
0.079), and significantly decreased in Apoe
–/–
Ncc
–/–
mice (P < 0.02), but Apoe
–/–
Ncc
–/–
Il18r
–/–
mice showed a greater decrease (P < 0.003). NCC inactivation with a thiazide 
diuretic (hydrochlorothiazide) in Apoe
–/–
and Apoe
–/–
Il18r
–/–
mice affirmed a modulatory 
role for IL18 in atherosclerosis mediated by IL18r and NCC. Thiazide reduced aortic root 
lesion intima area, lesion macrophage and MHC-II contents in Apoe
–/–
Il18r
–/–
mice but not 
in Apoe
–/–
mice. Thiazide showed no effect on lesion CD4
+
T cell content 
(Supplementary Fig. 5a). Consistent with prior observations
14,15
, IL18 administration to 
Apoe
–/–
mice accentuated atherogenesis with increased intima size and lesion macrophage 
and MHC-II content, although IL18 did not affect lesion T cell number. In contrast, IL18 
lacked these effects in Apoe
–/–
Ncc
–/–
Il18r
–/–
mice (Supplementary Fig. 5b). Prior studies
3
and our unpublished observation (data not shown) demonstrated significantly increased 
plasma cholesterol (P < 0.001) and triglyceride (P < 0.01) in IL18-deficeint Apoe
–/–
mice. 
Apoe
–/–
Il18r
–/–
mice also had increased plasma cholesterol and triglyceride compared with 
Apoe
–/–
mice. Apoe
–/–
Ncc
–/–
Il18r
–/–
mice, however, had significantly increased plasma 
HDL (P < 0.003) and decreased LDL (P = 0.025) (Supplementary Fig. 6).
7In humans and mice, defective NCC leads to hypomagnesemia, hypokalemia, or 
metabolic alkalosis
21,22
, kidney tubular disorders that can influence atherosclerosis 
indirectly
23
. IL18 actions on the plaque itself may not solely determine reduced 
atherosclerosis in Apoe
–/–
Ncc
–/–
Il18r
–/–
mice. Apoe
–/–
Ncc
–/–
(P < 0.001) and Apoe
–/–
Ncc
–/–
Il18r
–/–
(P < 0.001) mice both had significantly reduced plasma Mg
2+
, whereas only 
Apoe
–/–
Ncc
–/–
Il18r
–/–
mice (P = 0.005) had reduced plasma K
+
. Plasma pH did not differ 
among the four groups of mice (Supplementary Fig. 7). Apoe
–/–
and Apoe
–/–
Ncc
–/–
mice 
had similar atherosclerotic lesions sizes (Fig. 3a/3b), minimizing the confounding effects 
of hypomagnesemia or metabolic alkalosis on atherosclerosis in Apoe
–/–
Ncc
–/–
Il18r
–/–
mice, although the role of hypokalemia in atherosclerosis remains unknown. Bone 
marrow transplantation (BMT) from Apoe
–/–
Ncc
–/–
Il18r
–/–
mice demonstrated significantly 
smaller aortic root intima areas (P = 0.002), thoracic-abdominal aorta lipid deposition (P
= 0.024), aortic root lesion content of macrophages (P = 0.009) and lipids (P = 0.02), and 
plasma total cholesterol (P = 0.046) and LDL (P = 0.04) in Apoe
–/–
Ncc
–/–
Il18r
–/–
recipient 
mice than those receiving BMT from Apoe
–/–
or Apoe
–/–
Il18r
–/–
mice. Yet, Apoe
–/–
Ncc
–/–
Il18r
–/–
recipient mice that received bone marrow from the various mutant mice showed 
no significant differences in aortic root lesion T-cell number, MHC class-II-positive area, 
SMC content, or plasma K
+
, Mg
2+
, or pH (Fig. 3a-3e and Supplementary Fig. 6/7). 
These observations suggest that IL18r- and NCC-mediated IL18 activation of bone 
marrow-derived leukocytes and possibly vascular cells, rather than kidney tubular 
disorders or electrolyte disturbances, engendered reduced atherosclerosis in Apoe
–/–
Ncc
–/–
Il18r
–/–
mice.
8IL18 induces cytokine expression in inflammatory diseases
2,3,6,15
. Serum IL18 
levels in human subjects with atherosclerosis correlate with carotid intima thickness and 
other biomarkers of inflammation
24,25
. Apoe
–/–
Ncc
–/–
Il18r
–/–
mice showed the greatest 
reductions of plasma IFN-, IL6, and IL18, compared with the other three groups of 
mice, although Apoe
–/–
Il18r
–/–
or Apoe
–/–
Ncc
–/–
mice also had lower plasma IL6 and/or 
IL18 (Fig. 3f). These findings suggest that both IL18r and NCC contribute to IL18-
induced cytokine production. BMT of Apoe
–/–
Ncc
–/–
Il18r
–/–
recipient mice supported this 
hypothesis. Apoe
–/–
Ncc
–/–
Il18r
–/–
recipient mice receiving BMT from Apoe
–/–
Ncc
–/–
Il18r
–/–
mice showed significantly lower plasma IFN- (P = 0.026), IL6 (P = 0.012), and IL18 (P
= 0.004) than mice receiving BMT from Apoe
–/–
and Apoe
–/–
Il18r
–/–
mice (Fig. 3f).
Although the T cell content of lesions from mice of the different genotypes or from Apoe
–
/–
Ncc
–/–
Il18r
–/–
mice receiving BMT from different donors did not differ (Fig. 3c), IL18r 
and NCC expression determined IL18-induced IFN- and IL6 production from T cells. 
IL18 with or without IL12, which augments IL18 actions by inducing targeting cell IL18r 
expression and Th1 cell differentiation
6,26
, induced IFN- and IL6 expression in T cells 
from Apoe
–/–
mice. In contrast, production of both cytokines declined in T cells from 
Apoe
–/–
Ncc
–/–
and Apoe
–/–
Il18r
–/–
, and declined further in Apoe
–/–
Ncc
–/–
Il18r
–/–
mice (Fig. 
3g).
Macrophages also elaborate circulating cytokines. Recombinant IL18 promotes 
atherogenesis and enhances circulating cytokine levels in the absence of T cells
14,15
.
Macrophages express IL18r and NCC in atherosclerotic lesions or after stimulation with 
inflammatory mediators (Fig. 2b-2e)
12,13
. NCC may mediate IL18 actions on 
macrophages in the absence of IL18r, and vice versa. FITC-conjugated IL18 binding to 
9NCC on macrophages (from Apoe
–/–
Il18r
–/–
mice) showed a similar binding affinity (Kd =
21.39 nM) (Fig. 4a) to that of IL18 to IL18r on cells of human lymphoma line L428 (Kd
= 18.5 nM)
4
. When treated with IL18, macrophages from Apoe
–/–
, Apoe
–/–
Ncc
–/–
, or Apoe
–
/–
Il18r
–/–
mice showed phosphorylation of extracellular-signal–regulated kinases 
(ERK1/2) and p38 mitogen-activated protein kinase (MAPK) — regulators of cell 
growth, proliferation, differentiation, and inflammatory responses
27,28
. Yet, macrophages 
from Apoe
–/–
Ncc
–/–
Il18r
–/–
mice exposed to IL18 showed neither ERK1/2 nor p38 
phosphorylation (Fig. 4b), suggesting that IL18r and NCC cooperatively mediate IL18 
binding and cell signaling. Consistently, IL18 augmented IL6, IFN-, and monocyte 
chemotactic protein-1 (MCP-1) mRNA (Supplementary Fig. 8) and culture media 
protein levels (Fig. 4c/d) in macrophages from Apoe
–/–
, Apoe
–/–
Ncc
–/–
, or Apoe
–/–
Il18r
–/–
mice, but macrophages from Apoe
–/–
Ncc
–/–
Il18r
–/–
mice showed a mild or negligible 
response to IL18. NCC blockade with a thiazide diuretic affirmed a coordinate role of 
NCC and IL18r in response to IL18 in macrophages. Hydrochlorothiazide treatment of 
macrophages from Apoe
–/–
Il18r
–/–
mice lowered the culture medium IL6 to the same level 
as in cells from Apoe
–/–
Ncc
–/–
Il18r
–/–
mice, but did not yield further reduction in cells 
from Apoe
–/–
Ncc
–/–
Il18r
–/–
mice (Fig. 4d). In macrophages from Apoe
–/–
Il18r
–/–
mice, 
hydrochlorothiazide reduced ERK1/2 phosphorylation, but had negligible effect in cells 
from Apoe
–/–
mice (Fig. 4d). STE20/SPS-1-related proline-alanine-rich protein kinase 
(SPAK) can activate NCC
29
. IL18 induced SPAK phosphorylation in macrophages from 
Apoe
–/–
, Apoe
–/–
Ncc
–/–
, and Apoe
–/–
Il18r
–/–
mice, but not in cells from Apoe
–/–
Ncc
–/–
Il18r
–/–
mice (Fig. 4e). Therefore, IL18-induced SPAK phosphorylation also required both NCC 
and IL18r. IL18-induced cytokine expression difference among IL1 and TNF--pre-
10
treated macrophages from all four groups of mice (Fig. 4c/4d) was specific to IL18. 
TGF-1 induced macrophage IL6 production independent of IL18r and NCC genotypes 
(data not shown).
The treatment of NCC-transfected COS-7 cells with IL18, with or without IL12, 
provided further evidence that NCC contributes to IL18 signaling and inflammatory 
cytokine production. NCC over-expression may affect cell volume
30
and intracellular Cl
–
levels
31
, and thereby affect cell signaling independent of IL18 binding
31,32
. NCC over-
expression yielded significantly enlarged COS-7 cell volume (P = 0.003), but did not 
change intracellular Cl
–
concentrations before or after NaCl addition, suggesting the 
integrity of NCC-expressing COS-7 cells (Supplementary Fig. 9)
33
. Increased cell 
volume may have caused higher baseline phosphorylation of the transcription factor 
STAT-3
34
and p38 MAPK in NCC-transfected COS-7 cells than in vector-transfected 
COS-7 cells (Fig. 4f). IL18 alone or in combination with IL12, however, induced 
phosphorylation of STAT-3 and p38 in NCC-transfected cells in 15~30 minutes, but not 
in vector-transfected cells (Fig. 4f). When three NCC point mutants at the NH2-terminal 
phosphorylation sites
31
, T53A, T58A, S71A, and one compound mutant, T53A-T58A-
S71A, were generated and expressed in COS-7 cells, IL18-induced ERK1/2 
phosphorylation declined substantially in T53A and T53A-T58A-S71A NCC-transfected 
COS-7 cells but not in those transfected with T58A or S71A (Fig. 4g), supporting a 
prominent role of the NH2-terminal Thr
53
of NCC in mediating IL18 signaling. The 
expression of several known NCC mutants identified in human subjects with Gitelman 
syndrome, including G439S, S475C, E121D, and Q1030R, of which had impaired 
thiazide-sensitive Na
+
uptake or cell membrane targeting
35,36
, tested further the role of 
11
IL18 in NCC activation. WT and G439S-transfected COS-7 cells had comparable IL18-
induced p-ERK1/2, while S475C- and E121D-transfected cells had enhanced IL18-
induced p-ERK1/2. Q1030R-transfected cells had blocked IL18-induced p-ERK1/2 (Fig. 
4h), consistent with their corresponding cell membrane targeting profiles
35,36
.
Immunoblot analysis using anti-p-NCC polyclonal antibody
37
on both whole cell lysate 
and cell membrane preparation from NCC- or vector-transfected COS-7 cells 
demonstrated functional NCC on COS-7 plasma membrane. P-NCC localized in cell 
membrane and whole cell lysate in NCC-transfected COS-7 cells after IL18 stimulation 
(Fig. 4i). NCC-transfected COS-7 cells elaborated IL6 after stimulation with IL18 with or 
without IL12 for 2 days, consistent with the cell signaling data presented in Fig. 4f-4i. In 
contrast, vector-transfected COS-7 cells did not release IL6 after IL18 treatment alone, 
and significantly less IL6 (P < 0.001) than did NCC-transfected cells after stimulation 
with both IL18 and IL12 (Fig. 4j, left). IL18-induced NCC phosphorylation, downstream 
signaling, and cytokine production did not require IL18r nor association with IL18r 
accessory protein (IL18rap). In NCC-transfected COS-7 cells, which do not express 
IL18r, co-transfection of Flag-tagged mouse IL18rap in pcDNA3.1 followed by 
immunoprecipitation with an anti-Flag antibody did not detect an association between 
NCC and IL18rap with or without IL18 treatment (Supplementary Fig. 10). The 
adoption of a previously established FlpIn-293 cell line that does not express IL18r (data 
not shown) but expresses a full-length NCC cDNA under a tetracycline-inducible 
promoter allowed for exploration of IL18 activity on NCC in other mammalian cells
37
.
Active IL18, but not heat-inactivated IL18, induced both NCC expression and 
phosphorylation in FlpIn-293 cells exposed to tetracycline, as detected by immunoblot 
12
(Fig. 4j, right two panels). In the kidney, NCC localizes primarily in distal tubular 
epithelial cells
38
and contributes to NaCl reuptake. Yet, tubular epithelial cells, 
glomerular parietal cells, mesangial cells, and endothelial cells can express IL18r
39
, an 
important participant in glomerulonephritis, by regulating inflammatory cell infiltration, 
IgG and complement deposition, and inflammatory cytokine production
12,40
. NCC and 
IL18r therefore have distinct roles in the kidney.
This study demonstrated that IL18r and NCC coordinately participate in 
atherosclerosis (Fig. 3a-3f, Supplementary Fig. 5a/5b), and that these IL18-binding 
proteins colocalize in vascular SMCs, ECs, and macrophages (Fig. 2b-2d, 
Supplementary Fig. 2). IL18r and NCC may mediate IL18 signaling independently (Fig. 
2h, Fig. 4)
16
or as a complex (Fig. 2d/2g), although informatic searches did not reveal 
sequence similarity between the intracellular domains of NCC and those of conventional 
cytokine receptors (data not shown). IL18-mediated NCC activation may also activate 
downstream cell signaling via increased cell volume or changes in intracellular Cl
–
concentrations (Supplementary Fig. 9)
31,32
. Yet, this study does not exclude the 
involvement of additional molecules, either cell membrane proteins or extracellular 
soluble proteins that may participate in IL18 and NCC interaction. IL18 may contribute 
to atherogenesis in part by activating macrophages (Fig. 4c/4d), T cells (Fig. 3g), and 
possibly other inflammatory cells, such as mast cells and neutrophils to produce IFN-, 
IL6, IL18, and other untested inflammatory cytokines. The NCC activity in ion flux in 
the kidney may have negligible influence on atherogenesis, as shown in our BMT 
experiments presented in Fig. 3a-3f and Supplementary Fig. 7. Other organs under 
13
inflammatory conditions may highly express NCC, which alongside IL18r, may mediate 
several important IL18 activities implicated in atherogenesis.
Method
Methods and any associated  references  are  available  on-line.
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Figure legends
Figure 1. Identification of alternative IL18-binding proteins. a. Aortic root lesion intima, 
Mac-3
+
macrophage, CD4
+
T cell, and -actin–positive SMC areas in Apoe
–/–
Il18r
–/–
and 
Apoe
–/–
mice. n=7-10 per group. b. FACS of ECs from Apoe
–/–
Il18r
–/–
and Apoe
–/–
mice 
after binding with biotin-IL18 with and without excessive non-labeled IL18, followed by 
incubation with PE-streptavidin. c. P-tyrosine immunoblot in ECs treated with and 
without IL18 or heat-inactivated IL18 for 30 minutes. Actin, loading control. d. IL18-
binding protein identification in ECs from Apoe
–/–
Il18r
–/–
mice. SDS-PAGE silver 
staining detected IL18-bound proteins in three sequential elutes from anti-IL18 antibody-
bound protein-A agarose beads pre-incubated with cell lysates from ECs treated with or 
without IL18.
Figure 2. Na-Cl co-transporter expression and characterization. a. Immunostaining of 
NCC in normal human (bar: 1000 µm) and mouse aortas (bar: 50 µm). b.
Immunostaining of NCC, IL18r, and CD68
+
macrophages in human atherosclerotic 
lesions. Negative controls rabbit and mouse (not shown) IgG. Bar: 500 µm. c.
Immunostaining of NCC in lesions from Apoe
–/–
mice. Macrophage, SMC, and EC areas 
were framed. Negative controls used lesions from Apoe
–/–
Ncc
–/–
mice. Bar: 200 µm, insert 
bar: 50 µm. d. Immunofluorescent staining of NCC and IL18r in macrophages, SMCs, 
and ECs from lesions from Apoe
–/–
mice. Bar: 50 µm. e. RT-PCR and immunostaining to 
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detect NCC in macrophages (bar: 50 µm) and T cells (bar: 20 µm) from Apoe
–/–
mice.
Immunostaining negative controls used macrophages from Apoe
–/–
Ncc
–/–
mice. f.
Immunoblots to detect NCC in cytokine-induced mouse ECs and SMCs. NCC doublets 
are indicated. Positive control used NCC-transfected COS-7 cell lysate. g. IL18r 
immunoprecipitation followed by NCC immunoblot to detect NCC-IL18r complexes in 
macrophages from Apoe
–/–
mice. Negative control used macrophages from Apoe
–/–
Ncc
–/–
mice. h. FACS to detect biotin-IL18 and heated biotin-IL18 binding to differently 
transfected COS-7 cells; Scatchard plot of FITC-IL18 binding affinity on NCC-
transfected COS-7 cells, and p-tyrosine immunoblot in NCC- or vector-transfected COS-
7 cells treated with different treatments. Actin, protein loading. Data in panels e and h are 
mean ± SEM from three to six independent experiments.
Figure 3. IL18r and NCC function in atherosclerosis. Aortic root lesion intima area (a), 
thoracic-abdominal aorta oil-red O staining with representative images shown to the 
right, bar: 1 cm (b), aortic root lesion Mac-3
+
macrophages, CD4
+
T cell numbers, and 
MHC class-II-positive areas (c), lesion SMC content (d), aortic root oil-red O positive 
areas (e), and plasma IFN-, IL6, and IL18 levels (f) in Apoe
–/–
, Apoe
–/–
Ncc
–/–
, Apoe
–/–
Il18r
–/–
and Apoe
–/–
Ncc
–/–
Il18r
–/–
mice and in Apoe
–/–
Ncc
–/–
Il18r
–/–
mice receiving BMT 
from Apoe
–/–
, Apoe
–/–
Il18r
–/–
and Apoe
–/–
Ncc
–/–
Il18r
–/–
mice, after consuming a Western 
diet for 12 weeks, n=7-11 per group. ELISA determined media IFN- and IL6 levels in 
CD4
+
T cells from different mice after stimulation without (control) or with IL18 and 
IL12 (g). Data in panel g are mean ± SEM from three independent experiments. 
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Figure 4. NCC binding, signaling, and cytokine and chemokine production in 
macrophages, COS-7 cells, and FlpIn-293 cells. a. Scatchard plot of FITC-IL18 binding 
affinity on macrophages from Apoe
–/–
Il18r
–/–
mice. b. p-ERK1/2 and p-p38 immunoblots
in macrophages from different mice treated with and without IL18. Total ERK1/2, 
loading control. c. ELISA determined medium INF- and MCP-1 in IL18-treated and 
untreated macrophages from different mice. d. ELISA determined media IL6 in 
macrophages from different mice and treated with and without IL8 and 
hydrochlorothiazide. p-EKR1/2 immunoblot of  macrophages from Apoe
–/–
and Apoe
–/–
Il18r
–/–
mice are shown to the right. e. p-SPAK immunoblot in macrophages from 
different mice as indicated. f. p-STAT3, p-p38, and p38 immunoblots of cell lysates from 
NCC- or vector-transfected COS-7 cells and stimulated with IL18, or IL18 with IL12. 
g/h. p-ERK1/2 immunoblot of COS-7 cells transfected with indicated cDNA construct in 
pcDNA31 (g) or pCI-neo (h) and stimulated with or without IL18 for 15 minutes. i.
Immunoblots to detect p-NCC in membrane fraction or total cell lysate from vector- or 
NCC-transfected COS-7 cells and stimulated with or without IL18. j. Medium IL6 
ELISA in COS-7 cells with different transfections and stimulations; immunoblots to 
detect total and p-NCC in FlpIn-293 cells induced with or without tetracycline, IL18, or 
heat-inactivated IL18. Immunoblot signal density quantifications are shown to the right. 
Data in panels a, c, d, and j are mean ± SEM from three to six independent experiments.
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On-line methods
Generation of Apoe
–/–
Il18r
–/–
, Apoe
–/–
Ncc
–/–
, and Apoe
–/–
Ncc
–/–
Il18r
–/–
mice, and 
atherosclerotic lesion characterization. Apoe
–/–
mice (C57BL/6, N12, The Jackson 
Laboratory, Bar Harbor, ME), Il18r
–/–
(C57BL/6, N10, The Jackson Laboratory) and Ncc
–
/–
mice (C57BL/6/129S background)
20
were crossbred to generate Apoe
–/–
, Apoe
–/–
Il18r
–/–
, 
Apoe
–/–
Ncc
–/–
, and Apoe
–/–
Ncc
–/–
Il18r
–/–
mice in C57BL/6/129S mixed background 
littermates. All four groups of mice had the same genetic background as confirmed by 
genome scanning performed by the Jackson Laboratory. In this study, we used 7 to 11 
mice per experimental group based on the availability from the crossbreeding. Male 6-
week-old mice consumed a Western diet (Research Diet, New Brunswick, NJ) for 12 
weeks to develop atherosclerosis. Before harvesting mouse aortas, we collected plasma 
samples for plasma cytokine measurement (IL6 and IFN-) with ELISA kits according to 
the manufacturer’s instructions (R&D Systems, Minneapolis, MN). To characterize 
mouse atherosclerotic lesions, we embedded aortic root in OCT compound (Sakura 
Finetek USA, Inc., Torrance, CA) and prepared seven slides that each contained three 6-
µm frozen serial sections through the aortic sinus. The lesions in the root of the aorta 
beneath all three-valve leaflets near the ostia of the coronary arteries were analyzed. To
characterize atherosclerotic lesion composition, we stained frozen sections for 
macrophages (Mac-3, 1:900, clone M3/84), CD4
+
T cells (CD4, 1:90, clone OX-35), 
MHC class-II (1:150, clone M5/114.15.2) (Pharmingen, San Diego, CA), and SMCs (-
actin, 1:750, #SAB2500963, Sigma, St. Louis, MO)
41
. We performed each staining on a 
single slide from the same level of aortic root for all experimental and control mice. 
Computer-assisted analysis (Image-Pro Plus) served to determine the lesion size, as well 
as lipid deposition and areas for specific cell types in the cross-sections from aortic roots 
from the same experiment by the same observer to minimize variations. All 
measurements were performed by manual selection of stained pixel threshold and 
presented as percent of positive (stained) area to the entire intimal area. CD4
+
T cells 
were counted and presented as number of T cells per square millimeter. Thoracic-
abdominal aortas were used for en-face preparation and oil-red O staining to detect lipid 
deposition
41,42
. Plasma IL6, IFN-, IL18 (eBioscience, San Diego, CA), cholesterol, 
triglyceride, and high-density lipoproteins (Fisher Scientific, Pittsburg, PA) were 
determined by ELISA according to the manufacturers. Plasma Mg
2+
and K
+ 
levels were 
determined using the cobas c501 clinical chemistry analyzer using ion selective 
electrodes for potassium testing and the colorimetric MG2 assay for magnesium testing 
(Roche Diagnostics, Indianapolis, IN). Specimens with gross hemolysis were excluded 
from testing. Investigators were blinded during mouse harvesting and lesion 
characterization. All animal procedures conformed to the Guide for the Care and Use of 
Laboratory Animals published by the U.S. National Institutes of Health and were 
approved by the Harvard Medical School Standing Committee on Animals (protocol 
#03759).
Bone marrow transplantation. Male 8-week-old Apoe
–/–
Ncc
–/–
Il18r
–/–
mice were 
subjected to 1000 rad of total body irradiation, followed by reconstitution of 2×10
6
bone 
marrow cells from Apoe
–/–
, Apoe
–/–
Il18r
–/–
, and Apoe
–/–
Ncc
–/–
Il18r
–/–
mice via tail-vein 
injection. All animals were allowed to recover for 4 weeks on a chow diet after BMT. 
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Recipient mice then consumed an atherogenic diet for 12 weeks to develop 
atherosclerosis.
Thiazide diuretics and IL18 treatments. Male 8-week-old Apoe
–/–
and Apoe
–/–
Il18r
–/–
mice received hydrochlorothiazide (25 mg/L in drinking water, Sigma) while consuming 
an atherogenic diet for 12 weeks according to a previously established protocol
43
. Male 8-
week-old Apoe
–/–
and Apoe
–/–
Ncc
–/–
Il18r
–/–
mice received daily intraperitoneal injections 
of recombinant mouse IL18 (30 ng/gram body weight in 200 µL saline, MBL 
International, Woburn, MA) or saline alone for four weeks as described
14
.
Detections of NCC and IL18r in atherosclerotic lesions, kidney, macrophages, and T 
cells. Frozen sections from human normal carotid artery, carotid atherosclerotic lesions, 
and fatty streaks were immunostained with rabbit anti-human/mouse NCC polyclonal 
(1:60, #AB3553, Millipore, Billerica, MA), mouse anti-human IL18r monoclonal (1:100, 
clone 70625, R&D Systems), mouse anti-CD68 monoclonal (1:900, clone KP1, Dako, 
Carpinteria, CA) antibodies, mouse IgG1 (1:50, clone MOPC-31C, Becton Dickinson, 
Franklin Lakes, NJ) and rabbit IgG (1:60, #I5006, Sigma). Frozen sections of mouse 
kidney, normal mouse aorta, and atherosclerotic lesions from Apoe
–/–
and Apoe
–/–
Ncc
–/–
mice were immunostained with anti-mouse NCC polyclonal antibodies (1:250) from 
Millipore (Billerica, MA) or those previously described
18,44
. To detect NCC expression in 
macrophages, cells were cultured on a 4-well chamber slide. After stimulation with or 
without IL18, the slide was fixed with 10% formalin, and immunostained with anti-
mouse NCC polyclonal antibody (1:250)
18,44
. T cells were treated with IL18, fixed with 
10% formalin, and immunostained with the same antibody (1:250) in a test tube followed 
by photograph. To colocalize NCC and IL18r in mouse atherosclerotic lesions, we 
applied rabbit anti-NCC antibody (1:60, Millipore) after a 1-hour block in PBS, 
supplemented with 10% normal goat serum and 2% BSA (bovine serum albumin) for 
overnight incubation at 4°C followed by goat anti-rabbit Alexa Fluor 555 (red, 1:500, 
#A-21428, Invitrogen, Carlsbad, CA). After extensive washing in PBS, mouse anti-IL18r 
antibodies were applied (1:50, R&D Systems) for 1.5 hours, followed by goat anti-mouse 
Alexa Fluor 488 (green, 1:300, #A-31561, Invitrogen). After nuclei staining with DAPI, 
slides were cover-slipped with Fluorescent Mounting Medium (DAKO) and analyzed by 
Inverted Nikon eclipse TE2000-U microscope.
Isolation of mouse ECs, SMCs, CD4
+
T cells, and macrophages. Primary ECs 
were isolated using positive immuno-selection, as previously described
45
. Briefly, a 
mouse lung was minced and incubated with 2 mg/ml collagenase type I (Worthington 
Biochemical Corp., Lakewood, NJ) at 37 °C in DMEM for 1 hour, followed by
incubation with anti-mouse CD31 (clone 390, Pharmingen)-coated DYNAL
® 
Magnetic 
Beads (Invitrogen) for 10 minutes. Cells were separated with a magnetic separator and 
cultured on 0.1% gelatin–coated plates. After the cells reached confluence, a second 
purification was performed with rat anti-mouse CD102 antibody (clone 3C4(mIC2/4), 
Pharmingen). EC purity was examined by flow cytometry with anti-CD31 antibody.
Mouse aortic SMCs were isolated by collagenase type II (Worthington) digestion of aorta 
for 10 minutes, and the adventitia and endothelia were removed with abrasion, followed 
by digestion with collagenase types I and III (Worthington) for 60 minutes
41
. Cells were 
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then plated on a fibronectin-coated plate. SMC identity was verified by immunostaining 
for  -actin. CD4
+
T cells were isolated from mouse spleen, as we reported previously
46
. 
Briefly, crude total T cells were separated from splenocytes using a nylon-wool column 
(Polysciences, Inc., Warrington, PA). Crude preparation was used to deplete antigen-
presenting cells and CD8
+
T cells by two rounds of incubation with I-A
b
and CD8 
monoclonal antibodies (clone AF6-120.1 and clone 53-6.7, Pharmingen) for 30 minutes 
at 4 ºC, followed by lysis with low-tox complement (Accurate Chemical and Science 
Corp., Westbury, NY) at 37 ºC for 30 minutes. To obtain macrophages, mice were 
intraperitoneally injected with 3% thioglycollate (Sigma). After 72 hours, peritoneal cells 
were collected and cultured with RPMI 1640 in a plate overnight. After suspended cells 
were removed, macrophages adhered to the plate were used for further experiments.
IL18-binding Na-Cl co-transporter identification. An immunoprecipitation kit 
(Promega, Madison, WI) was used to isolate IL18 binding proteins. Briefly, ECs from 
Il18r
–/–
mice were incubated with recombinant mouse IL18 (PeproTech, Inc., Rocky Hill, 
NJ, 50 ng/ml) for 15 minutes at 37 ºC, washed with ice-cold PBS, lysed in a lysis buffer 
from the immunoprecipitation kit, and centrifuged at 14000 rpm for 15 minutes. The 
supernatant was passed through an IL18 polyclonal antibody (#5180R, BioVision, Inc., 
Milpitas, CA) pre-coated protein A agarose (Invitrogen) column, followed by extensive 
washes. Bound proteins were eluted according to the manufacturer’s instructions, and 
separated on an 8% SDS-PAGE. Silver staining displayed two bands of approximately 
80-kDa and 125-kDa, which were removed and analyzed with mass spectrometry 
(Brigham and Women’s Hospital Core Facility). 
Cloning and expression of mouse and human wild-type and mutant NCC and 
IL18rap. A full-length wild-type (WT) mouse NCC cDNA fragment was amplified 
from mouse EC RNA using RT-PCR, with a forward primer covering the start codon and 
a reverse primer covering the stop codon (NM_019415). Full-length cDNA subcloned 
into pcDNA3.1 (Invitrogen). NCC/pcDNA3.1 and empty vector were used for COS-7 
cell transfection with lipofectamine (Invitrogen). Site-direct mutagenesis was performed 
to replace three phosphorylation sites — Thr
53
, Thr
58
, and Ser
71
— or all three amino 
acids together located at the NH2-terminus of NCC with alanine, using the original 
NCC/pcDNA3.1 as a template (GenScript USA Inc., Piscataway, NJ). A full-length 
mouse IL18rap cDNA with a Flag tag at the COOH-terminus was subcloned to the same 
pcDNA3.1 expression vector (Bioclone, Inc., San Diego, CA). Human NCC cDNA was 
subcloned into the pCI-neo (Promega) and site-direct mutagenesis was used to generate 
G439S, S475C, E121D, and Q1030R mutants, followed by lipofectamine-mediated 
transfection into COS-7 cells.
Flow cytometry. Recombinant mouse IL18 was biotinylated with an EZ-link 
biotinylation kit (Pierce, Rockford, IL) according to the manufacturer’s instructions. ECs 
isolated from Apoe
–/–
and Apoe
–/–
Il18r
–/–
mice or COS-7 cells transfected with 
NCC/pcDNA 3.1 were incubated with 10 ng/ml biotin-IL18, in the absence or presence 
of unlabeled IL18, for 10 minutes or 30 minutes at 37ºC, followed by incubation with 
1:100 diluted PE-conjugated streptavidin (#562284, Pharmingen). After three washes, 
cells were subjected to flow cytometric analysis.
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Immunoblot, RT-PCR, ELISA, and cell volume measurement. To detect protein 
tyrosine phosphorylations, mouse ECs, wild-type or mutant NCC-transfected COS-7 
cells, or macrophages were starved overnight and then treated with or without IL18, heat-
inactivated IL18 (50~100 ng/ml), or IL12 (10 ng/ml) (PeproTech) for 15 to 30 minutes. 
Equal amounts of protein from each cell-type preparation were separated by SDS-PAGE, 
blotted, and detected with different antibodies, including p-tyrosine (1:1000, #309302, 
BioLegend, San Diego, CA), p-p38 MAPK (Thr
180
/Tyr
182
, #4511, 1:1000), and p-ERK 
(p-p44/42 MAPK, #9107, 1:1000); p-STAT3 (Ser727, #9136, 1:1000) (Cell Signaling 
Technology, Inc., Danvers, MA); p-NCC (1:500)
37
, p-SPAK (1:1000, obtained from the 
Division of Signal Transduction Therapy Unit at the University of Dundee), and -actin 
(1:3000, #A5441, Sigma). To detect NCC activation in COS-7 cells, we transfected COS-
7 cells with pcDNA3.1 or NCC/pcDNA3.1, followed by IL18 (100 ng/ml) treatment for 
15 minutes. Cell membrane fraction and cytosolic fraction were extracted according to 
the manufacturer’s instructions (Fraction PREP cell fractionation kit, BioVision). Equal 
amounts of protein were separated by SDS-PAGE and detected with phospho-NCC
37
and 
total NCC (Millipore) polyclonal antibodies (1:1000). Transfected COS-7 cells were 
photographed, and cell volumes were measured using computer-assisted analysis (Image-
Pro Plus). To express NCC in HEK293 cells, we used the Flp-In T-Rex mammalian 
expression system (Invitrogen), which permitted expression of NCC under the control of 
a tetracycline-inducible promoter, and allowed NCC to process normally by 
glycosylation and phosphorylation
37
. FlpIn-293 cells were maintained in a high-glucose 
DMEM containing 10% FBS, 200 μg/ml hygromycin, 15 μg/ml blasticidin, and 
penicillin/streptomycin. NCC induction was confirmed by incubating the cells with or 
without tetracycline (1 μg/ml). To stimulate NCC expression and phosphorylation, we 
pre-treated FlpIn-293 cells with or without tetracycline overnight
37
and then with or 
without IL18 (100 ng/ml) for another overnight, followed by cell lysis and 
immunoblotting using anti-total-NCC
44
or anti-phospho-NCC
37
rabbit polyclonal 
antibodies.
To detect NCC expression in mouse SMCs and ECs, cells were starved overnight 
and then stimulated with IL18 (50 ng/ml), IL1 (10 ng/ml), or TNF- (10 ng/ml) 
(PeproTech) for 2 days. Immunoblot was used to detect NCC expression in these cells 
using rabbit anti-mouse NCC polyclonal antibody (1:1000, Millipore).
To detect cytokine (IL6 and IFN-) and chemokine (MCP-1) expression in CD4
+
T cells, peritoneal macrophages, and COS-7 cells, cells were starved overnight and then 
stimulated with IL18 (50~100 ng/ml, MBL International), IL18 with IL12 (10 ng/ml, 
PeproTech), hydrochlorothiazide (200 µM, Sigma)
47
, or TGF-1 (10 ng/ml, R&D 
Systems) for 2 days. Macrophages were pre-incubated with IL1 and TNF- for 2 days 
to induce NCC expression before other treatments. Cell culture media were collected to 
measure medium cytokines and chemokines with ELISA kits, according to the 
manufacturer’s instructions (R&D Systems). Cells were collected for total RNA 
preparation and RT-PCR analysis (Bio-Rad, Hercules, CA) to detect IL6, IFN-, and 
MCP-1 mRNA levels.
NCC co-immunoprecipitation with IL18rap and IL18r. Flag-IL18rap and NCC 
plasmids were transfected into COS-7 cells with lipofectamine 2000 (Invitrogen). After 
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48 hours, cells were treated with or without IL18 (100 ng/ml) for 15 minutes and then 
lysed in a RIPA buffer containing 50 mM Tris, pH 7.4, 150 mM NaCl, 2 mM EDTA, 1% 
NP-40, 0.1% SDS, 5 μg/ml aprotinin, 5 μg/ml leupeptin, and 1 mM phenylmethylsulfonyl 
fluoride. To detect the protein expression, an equal amount of protein from each 
preparation was separated by SDS-PAGE, blotted, and detected with different antibodies, 
including Flag (1:1000, clone M2, Sigma), NCC (1:1000)
37
, and β-actin (1:3000, Sigma). 
For immunoprecipitation, cell lysates were pre-cleared for 1 hour with protein A/G 
agarose (Santa Cruz Biotechnology Inc., Dallas, TX), followed by incubating overnight 
with 1 μg anti-Flag antibody (Sigma) and protein A/G agarose for an additional hour. 
Immunoprecipitates were then washed four times with 1 ml cell lysis buffer, followed by 
separation on 8% SDS-PAGE for immunoblot analysis with rabbit anti–mouse NCC 
polyclonal antibody (1:1000)
37
.
To detect the interaction between NCC and IL18r, we used macrophages from 
Apoe
–/–
and Apoe
–/–
Ncc
–/–
mice instead of transfecting NCC together with all three chains 
of IL18r to COS-7 cells, which may affect IL18r function. Macrophages were treated 
with and without IL18 for 30 min and cell lysates (300 µg per sample) were 
immunoprecipitated with rat anti-mouse IL18r monoclonal antibody (clone 112624, R&D 
Systems) followed by immunoblot with rabbit anti-NCC polyclonal antibody (Millipore) 
to detect NCC-IL18r complexes.
IL18 binding and Scatchard plot analysis. Mouse recombinant IL18 (PeproTech) was 
conjugated with FITC using a Sigma FITC conjugation kit. Briefly, IL18 was diluted at 
5.0 mg/ml in 0.1 M carbonate-bicarbonate buffer, pH 9.0, and combined with 50 µl FITC 
solution with different dilutions (5:1, 10:1, 20:1), according to the manufacturer’s 
instructions. Reaction was carried at room temperature under dark for 2 hours. FITC-
conjugated IL18 was purified over a Sephadex G-25M column.
Binding assay was performed according to an established protocol from 
PerkinElmer, Inc. (DELFIA® Eu-Labled IL18). In brief, COS-7 cells or mouse peritoneal 
macrophages were resuspended in a buffer containing 20 mM HEPES and 10 mM 
EDTA, pH 7.5, and incubated at 4 ºC for 15 minutes. Cells were then homogenized and 
centrifuged at 28000 rpm, at 4 ºC for 30 minutes. Cell pellet was resuspended into a 
storage buffer containing 20 mM HEPES and 1 mM EDTA, pH 7.5, and rehomogenized 
with polytron PT3100 homogenizer. An equal amount of protein was incubated with 
FITC-IL18 in a binding buffer (50 mM Tris-HCL, 5 mM MgCl2, 25 µM EDTA, 0.2% 
BSA) for 90 minutes at room temperature in an AcroWell
TM
96 Filter Plate (Pall Corp., 
Port Washington, NY). The plate was then washed four times with 50 mM Tris-HCl and 
5 mM MgCl2. The plate was read at 494 nm excitation and 518 nm emission. Scatchard 
analysis was performed using the Prism 3.02 software (GraphPad Software Inc., La Jolla, 
CA). To test FITC-IL18 binding affinity on NCC from COS-7 cells, which do not express 
IL18r (data not shown), we used NCC-transfected COS-7 cells. Empty vector-transfected 
COS-7 cells were used for background controls. To test FITC-IL18 binding affinity on 
macrophages, we used adhesion depletion-purified peritoneal macrophages from Apoe
–/–
Il18r
–/–
mice, and the same cells from Apoe
–/–
Ncc
–/–
Il18r
–/–
mice were used as background 
controls. Data were presented as the mean of three to five experiments.
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Intracellular chloride measurements. To detect intracellular chloride 
concentration, COS-7 cells were transfected with pcDNA3.1 or NCC/pcDNA3.1 for 2 
days. Intracellular chloride concentration was then monitored by a chloride-sensitive 
fluorescent dye, n-(ethoxycarbonylmethyl)-6-methoxyquinolinium (MQAE), as 
described
33
. Briefly, cells were first incubated with 10 mM MQAE in a loading buffer 
[DMEM, 0.1% BSA, 10 mM 4-(2-hydroxyethyl)-1-piperazine-ethanesulphonic acid 
(HEPES), pH 7.5] for 45 minutes at 37 °C. Cells were then washed with DMEM or with
chloride-free medium (101 mM sodium gluconate, 5 mM potassium gluconate, 2 mM 
MgSO4, 2 mM calcium acetate, 10 mM HEPES, pH 7.5, 10 mM glucose), and 
fluorescence was excited at 350 nm and detected at 460 nm. The time course of MQAE 
was monitored using a fluorescence spectrophotometer Wallac (Perkin Elmer) for 5 
minutes, followed by the addition of NaCl (25 mM) for 5 minutes. Reduction of 
intracellular (efflux) chloride concentration is expected as an increase in fluorescence.
Statistical analysis. We used the non-parametric Mann-Whitney test followed by 
Bonferroni correction to examine the statistical significance between the groups, due to 
the relatively small sample sizes and often skewed distributions. P < 0.05 was considered 
statistically significant. All data were expressed as mean ± SEM. The availability and our 
prior experience, but not Power Calculation determined the number of mice in each 
experimental group. No data point was excluded.  
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